Equities research analysts expect Sotera Health (NYSE:SHC) to announce $236.45 million in sales for the current quarter, Zacks reports. Three analysts have made estimates for Sotera Health’s earnings, with estimates ranging from $234.90 million to $238.91 million. Sotera Health reported sales of $216.85 million during the same quarter last year, which would suggest a positive year over year growth rate of 9%. The company is expected to issue its next earnings report on Tuesday, March 8th.
According to Zacks, analysts expect that Sotera Health will report full-year sales of $926.68 million for the current financial year, with estimates ranging from $925.10 million to $929.14 million. For the next year, analysts expect that the company will post sales of $1.02 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for Sotera Health.
Sotera Health (NYSE:SHC) last announced its quarterly earnings results on Wednesday, November 10th. The company reported $0.21 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.02. Sotera Health had a return on equity of 35.74% and a net margin of 4.10%. The firm had revenue of $226.16 million for the quarter, compared to analysts’ expectations of $222.55 million.
Shares of SHC traded up $0.10 during midday trading on Thursday, hitting $21.91. 657,454 shares of the company traded hands, compared to its average volume of 987,015. The stock has a 50-day moving average of $25.20 and a 200-day moving average of $24.38. Sotera Health has a one year low of $21.18 and a one year high of $30.38. The firm has a market cap of $6.20 billion and a P/E ratio of 182.60. The company has a debt-to-equity ratio of 3.39, a current ratio of 2.52 and a quick ratio of 2.46.
Institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its stake in shares of Sotera Health by 22.0% during the third quarter. Bank of New York Mellon Corp now owns 352,968 shares of the company’s stock valued at $9,230,000 after purchasing an additional 63,674 shares during the period. ArrowMark Colorado Holdings LLC boosted its stake in shares of Sotera Health by 5.3% during the third quarter. ArrowMark Colorado Holdings LLC now owns 2,972,824 shares of the company’s stock valued at $77,739,000 after purchasing an additional 150,724 shares during the period. Aurora Investment Counsel purchased a new stake in shares of Sotera Health during the third quarter valued at approximately $1,453,000. Squarepoint Ops LLC boosted its stake in shares of Sotera Health by 1.7% during the third quarter. Squarepoint Ops LLC now owns 123,000 shares of the company’s stock valued at $3,216,000 after purchasing an additional 2,000 shares during the period. Finally, Stockbridge Partners LLC boosted its stake in shares of Sotera Health by 5.7% during the third quarter. Stockbridge Partners LLC now owns 9,937,488 shares of the company’s stock valued at $259,865,000 after purchasing an additional 532,903 shares during the period. 86.95% of the stock is owned by institutional investors and hedge funds.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
Featured Story: What are the most popular ETFs
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.